Patent · US Active

Materials and methods for treatment of pain related disorders

US11459587B2 · kind B2 · utility

1Cited by
140References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2017
Grant dateOct 4, 2022
Priority date
Expiry dateJun 5, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides materials and methods for treating a patient with one or more conditions associated with SCN9A whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of SCN9A gene in a cell by genome editing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.